1例多方案评估帕金森病睡眠障碍治疗疗效的病例报告

doi:10.16150/j.1671-2870.2018.04.020

诊断学理论与实践 ›› 2018, Vol. 17 ›› Issue (04): 457-459.doi: 10.16150/j.1671-2870.2018.04.020

1例多方案评估帕金森病睡眠障碍治疗疗效的病例报告

严振鹏¹, 杨月嫦^2a, 吴惠涓^2a,2b, 陈坤^2a,2b, 徐云霞^2a,2b

1.海军军医大学基础医学院四大队学员十二队,200433;
2.海军军医大学附属长征医院 a. 神经内科,b. 睡眠障碍诊疗中心,200003

收稿日期:2018-07-26 出版日期:2018-08-25 发布日期:2018-08-25
通讯作者: 杨月嫦 E-mail: yuechangyang@smmu.edu.cn

Received:2018-07-26 Online:2018-08-25 Published:2018-08-25

摘要/Abstract

关键词: 帕金森病, 睡眠障碍, 多导睡眠监测, 心肺耦合分析

中图分类号:

R742.4

严振鹏, 杨月嫦, 吴惠涓, 陈坤, 徐云霞. 1例多方案评估帕金森病睡眠障碍治疗疗效的病例报告[J]. 诊断学理论与实践, 2018, 17(04): 457-459.

[1] Marinus J, Zhu K, Marras C, et al.Risk factors for non-motor symptoms in Parkinson's disease[J]. Lancet Neurol,2018,17(6):559-568.
[2] Suzuki K, Miyamoto M, Miyamoto T, et al.Parkinson's disease and sleep/wake disturbances[J]. Curr Neurol Neurosci Rep,2015,15(3):8.
[3] Mehta SH, Morgan JC, Sethi KD.Sleep disorders asso-ciated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment[J]. CNS Spectr,2008,13(Suppl 4):6-11.
[4] Neikrug AB, Maglione JE, Liu L, et al.Effects of sleep disorders on the non-motor symptoms of Parkinson di-sease[J]. J Clin Sleep Med,2013,9(11):1119-1129.
[5] Xiang W, Sun Y Q, Teoh H C.Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations[J]. Drug Des Devel Ther,2018,12:2017-2024.
[6] Selvaraj VK, Keshavamurthy B. Sleep Dysfunction in Parkinson's Disease[J]. J Clin Diagn Res,2016,10(2):OC09-12.
[7] Maiga B, Diop MS, Sangare M, et al.Sleep quality assessment in 35 Parkinson's disease patients in the Fann Teaching Hospital, Dakar, Senegal[J]. Rev Neurol (Paris),2016,172(3):242-247.
[8] Bostantjopoulou S, Katsarou Z, Karakasis C, et al.Evalua-tion of non-motor symptoms in Parkinson's Disease: An underestimated necessity[J]. Hippokratia,2013,17(3):214-219.
[9] Suzuki K, Miyamoto T, Miyamoto M, et al.Evaluation of cutoff scores for the Parkinson's disease sleep scale-2[J]. Acta Neurol Scand,2015,131(6):426-430.
[10] Mollayeva T, Thurairajah P, Burton K, et al.The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis[J]. Sleep Med Rev,2016,25:52-73.
[11] Thompson E.Hamilton Rating Scale for Anxiety (HAM-A)[J]. Occup Med (Lond), 2015, 65(7):601.
[12] Torbey E, Pachana NA, Dissanayaka NN.Depression ra-ting scales in Parkinson's disease: A critical review updating recent literature[J]. J Affect Disord,2015,184:216-224.
[13] Lee DH, Cho CH, Han C, et al.Sleep Irregularity in the Previous Week Influences the First-Night Effect in Polysomnographic Studies[J]. Psychiatry Investig,2016, 13(2):203-209.
[14] Thomas RJ, Mietus JE2, Peng CK, et al. Relationship between delta power and the electrocardiogram-derived cardiopulmonary spectrogram: possible implications for assessing the effectiveness of sleep[J]. Sleep Med,2014, 15(1):125-131.
[15] Frampton J E.Pramipexole extended-release: a review of its use in patients with Parkinson's disease[J]. Drugs,2014,74(18):2175-2190.
[16] Armitage R, Trivedi M, Hoffmann R, et al.Relationship between objective and subjective sleep measures in depressed patients and healthy controls[J]. Depress Anxiety,1997,5(2):97-102.
[17] Feige B, Al-Shajlawi A, Nissen C, et al.Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients[J]. J Sleep Res,2008,17(2):180-190.
[18] Tamaki M, Nittono H, Hayashi M, Hori T, et al.Examination of the first-night effect during the sleep-onset pe-riod[J]. Sleep,2005,28(2):195-202.
[19] Thomas RJ, Mietus JE, Peng CK, et al.An electrocardiogram-based technique to assess cardiopulmonary coupling during sleep[J]. Sleep,2005,28(9):1151-1161.
[20] Chen L, Liu C, Ye Z, et al.Assessment of sleep quality using cardiopulmonary coupling analysis in patients with Parkinson's disease[J]. Brain Behav,2018,8(5):e00970.

1例多方案评估帕金森病睡眠障碍治疗疗效的病例报告

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	武冬冬, 陈玉辉, 刘芳, 刘银红, 蒋景文. 脑小血管疾病合并中枢神经系统退行性疾病机制的研究进展[J]. 诊断学理论与实践, 2022, 21(05): 644-649.
[2]	陈施吾, 窦荣花, 王玉凯, 王含, 王晓平, 陈先文, 陈玲, 王训, 屈洪党, 陈生弟, Susan Fox, 李燕, 王刚. 帕金森病血压管理专家共识[J]. 诊断学理论与实践, 2020, 19(05): 460-468.
[3]	邵丹丹, 付洋, 罗琪, 陈捷, 马建芳, 黄雷. 血清尿酸水平与帕金森病发病间关系的前瞻性研究[J]. 诊断学理论与实践, 2020, 19(02): 139-144.
[4]	武冬冬, 刘银红, 蒋景文, 陈海波. 放射性核素在帕金森病诊断中的应用[J]. 诊断学理论与实践, 2018, 17(06): 726-730.
[5]	刘春风, 徐兴, 沈赟. 多导睡眠监测在帕金森病伴发睡眠障碍诊断中的应用[J]. 诊断学理论与实践, 2018, 17(04): 377-381.
[6]	曹学兵, 曾玮琪, 徐岩. 帕金森病冻结步态诊疗研究进展[J]. 诊断学理论与实践, 2018, 17(04): 382-386.
[7]	崔海伦, 张一帆, 管晓军, 黄沛钰, 刘志蓉, 袁园, 刘晓云, 朱红灿, 曹学兵, 陈玲, 陈先文, 陈燕, 商慧芳, 杨任民, 陈生弟, 张敏鸣, 王刚. 帕金森病及相关运动障碍的神经影像学诊断专家共识[J]. 诊断学理论与实践, 2018, 17(04): 403-408.
[8]	崔诗爽, 陈生弟, 王刚. 帕金森病体液生物标志物研究进展[J]. 诊断学理论与实践, 2018, 17(04): 471-476.
[9]	邹扬, 崔海伦, 胡勇博, 高颖, 张月琪, 陈生弟, 王刚. 运动诱发电位用于鉴别诊断原发性帕金森病和多系统萎缩的临床研究[J]. 诊断学理论与实践, 2018, 17(04): 409-413.
[10]	贺娜英, 许洪敏, 黄沛, 陈生弟, 严福华, 凌华威. 基于定量磁化率图像观察帕金森病患者黑质体-1退变的研究[J]. 诊断学理论与实践, 2017, 16(02): 147-151.
[11]	邹扬, 胡勇博, 高颖, 张月琪, 陈生弟, 王刚,. 长病程帕金森病患者的运动诱发电位研究[J]. 诊断学理论与实践, 2016, 15(02): 124-127.
[12]	胡以松,. 从流行病学的角度看待我国的帕金森病筛查[J]. 诊断学理论与实践, 2016, 15(02): 118-121.
[13]	张月琪, 王刚,. 国际运动障碍疾病协会帕金森病临床诊断新标准(2015)介绍[J]. 诊断学理论与实践, 2016, 15(02): 122-123.
[14]	沈博, 尤志菲, 王晓平,. 丘脑底核脑深部电刺激对帕金森病认知功能影响[J]. 诊断学理论与实践, 2016, 15(02): 128-132.
[15]	商慧芳, 陈永平,. 帕金森病生物标志物的研究现状及展望[J]. 诊断学理论与实践, 2016, 15(02): 92-95.